Akanda Corp logo

Akanda Corp (Y232)

Market Open
12 Jun, 20:00
16. 00
+4.5
+39.1304%
- Market Cap
- P/E Ratio
- Div Yield
300 Volume
- Eps
11.5
Previous Close
Add Transaction
Day Range
12.9 18.2
Year Range
1.8 149.4
Want to track Y232 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

Y232 trading today higher at €16, an increase of 39.1304% from yesterday's close, completing a monthly decrease of -63.6364% or -€28. Over the past 12 months, Y232 stock gained 86.1547%.
Y232 is not paying dividends to its shareholders.
Akanda Corp has completed 6 stock splits, with the recent split occurring on Apr 13, 2026.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

Y232 Chart

Akanda Corp. (NASDAQ:AKAN) Short Interest Down 80.7% in April

Akanda Corp. (NASDAQ:AKAN) Short Interest Down 80.7% in April

Akanda Corp. (NASDAQ: AKAN - Get Free Report) saw a large drop in short interest in April. As of April 15th, there was short interest totaling 21,399 shares, a drop of 80.7% from the March 31st total of 110,750 shares. Based on an average daily volume of 29,824 shares, the short-interest ratio is currently 0.7 days.

Defenseworld | 1 month ago
Why Is Akanda (AKAN) Stock Up 34% Today?

Why Is Akanda (AKAN) Stock Up 34% Today?

Akanda (NASDAQ: AKAN ) stock is on the rise Friday alongside heavy pre-market trading of the cannabis company's shares this morning. This has more than 6.8 million shares of AKAN stock changing hands as of this writing.

Investorplace | 1 year ago
Penny Stocks That Pack a Punch: 3 Names to Ride for 10X Gains

Penny Stocks That Pack a Punch: 3 Names to Ride for 10X Gains

One of the many advantages of penny stocks is that you can easily create a customized portfolio. diversified across various sectors, geographies, and business types, allowing for the creation of a tailored portfolio that aligns closely with individual investment goals.

Investorplace | 2 years ago

Akanda Corp (Y232) FAQ

What is the stock price today?

The current price is €16.00.

On which exchange is it traded?

Akanda Corp is listed on XFRA.

What is its stock symbol?

The ticker symbol is Y232.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Akanda Corp ever had a stock split?

Akanda Corp had 6 splits and the recent split was on Apr 13, 2026.

Akanda Corp Profile

Specialty Retail Industry
Consumer Discretionary Sector
Katharyn Field CEO
XFRA Exchange
CA00971M7008 ISIN
GB Country
46 Employees
- Last Dividend
13 Apr 2026 Last Split
- IPO Date

Overview

Akanda Corp. stands as an integral player in the global cannabis industry, with its primary focus on the cultivation, manufacturing, and distribution of cannabis-based products for medicinal purposes. Incorporating in 2021, the company swiftly positioned itself in New Romney, the United Kingdom, as a frontrunner in providing cannabis-based medicinal solutions. Through its subsidiaries, Akanda Corp. extends its reach worldwide, aiming to address and fulfill the increasing demand for medicinal-grade cannabis by leveraging innovative cultivation techniques and processing methods to ensure high-quality product output.

Products and Services

  • Medicinal-grade Cannabis:

    This product line exemplifies Akanda Corp.'s commitment to quality and therapeutic efficacy. Cultivated under strictly controlled conditions, their medicinal-grade cannabis is designed to meet the precise needs of patients worldwide. By adhering to the highest standards of production, Akanda ensures that its cannabis products maintain consistency in potency and purity, essential for effective medical treatment and patient relief.

  • Cannabis-based Medical and Wellness Products:

    Expanding beyond raw cannabis, Akanda Corp. offers a diverse range of products tailored for medical and wellness applications. These encompass various formulations and delivery methods, including tinctures, capsules, topicals, and edibles, developed to facilitate ease of use and optimize therapeutic outcomes. By integrating innovative research and development practices, the company also seeks to continuously evolve its product offerings, thereby supporting patients' diverse needs and improving their quality of life.

Contact Information

Address: 1a, 1b Learoyd Road
Phone: 44 20 3488 9514